Preventing platelet thrombosis with a PAR1 pepducin.
Ahmed
A
Abdel-Latif
Susan S
SS
Smyth
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D055666:Lipopeptides / Q000494:pharmacology / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D044463:Receptor, PAR-1 / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*
C552958:F2pal-16 pepducin; D055666:Lipopeptides; D010975:Platelet Aggregation Inhibitors; D044463:Receptor, PAR-1